Literature DB >> 14715358

Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction.

J Eduardo Rame1, Marlon Ramilo, Nali Spencer, Christopher Blewett, Sameer K Mehta, Daniel L Dries, Mark H Drazner.   

Abstract

The progression from concentric left ventricular (LV) hypertrophy to heart failure has not been well defined. Of 159 predominantly hypertensive African-American patients with LV hypertrophy and a normal ejection fraction (EF), 28 (18%) developed a reduced EF after a median follow-up of approximately 4 years. Risk factors for this outcome included a history of coronary artery disease, pulmonary edema seen on a chest x-ray, or a subsequent myocardial infarction.

Entities:  

Mesh：

Year:  2004        PMID： 14715358     DOI： 10.1016/j.amjcard.2003.09.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

2.  The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern.

Authors:  Wolfgang Lieb; Philimon Gona; Martin G Larson; Jayashri Aragam; Michael R Zile; Susan Cheng; Emelia J Benjamin; Ramachandran S Vasan
Journal:  JACC Cardiovasc Imaging       Date:  2014-08-13

3.  Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.

Authors:  Rozenn N Lemaitre; Paul N Jensen; Andrew Hoofnagle; Barbara McKnight; Amanda M Fretts; Irena B King; David S Siscovick; Bruce M Psaty; Susan R Heckbert; Dariush Mozaffarian; Nona Sotoodehnia
Journal:  Circ Heart Fail       Date:  2019-07-12       Impact factor: 8.790

Review 4.  Hypertension as a risk factor for heart failure.

Authors:  Arun Kannan; Rajesh Janardhanan
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.

Authors:  Barry A Borlaug; Margaret M Redfield
Journal:  Circulation       Date:  2011-05-10       Impact factor: 29.690

6.  Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

Authors:  N M Hawkins; D Wang; J J V McMurray; M A Pfeffer; K Swedberg; C B Granger; S Yusuf; S J Pocock; J Ostergren; E L Michelson; F G Dunn
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

7.  Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides.

Authors:  Mikkel Andreassen; Jens Faber; Andreas Kjær; Claus Leth Petersen; Lars Østergaard Kristensen
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

8.  Heart failure and cardiac hypertrophy.

Authors:  J Eduardo Rame; Daniel L Dries
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

9.  Hemodialysis-induced cardiac injury: determinants and associated outcomes.

Authors:  James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

10.  Increase in the late diastolic filling force is associated with impaired transmitral flow efficiency in acute moderate elevation of left ventricular afterload.

Authors:  Panupong Jiamsripong; Anna M Calleja; Mohsen S Alharthi; Eun Joo Cho; Eileen M McMahon; Jeffrey J Heys; Michele Milano; Partho P Sengupta; Bijoy K Khandheria; Marek Belohlavek
Journal:  J Ultrasound Med       Date:  2009-02       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.